Manchester Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $231K | Sell |
788
-93
| -11% | -$30.6K | 0.03% | 251 |
|
|
2025
Q4 | $309K | Buy |
881
+92
| +12% | +$31.1K | 0.04% | 222 |
|
|
2025
Q3 | $255K | Sell |
789
-27
| -3% | -$8.4K | 0.03% | 275 |
|
|
2025
Q2 | $317K | Hold |
816
| – | – | 0.04% | 283 |
|
|
2025
Q1 | $355K | Buy |
816
+85
| +12% | +$34.1K | 0.04% | 257 |
|
|
2024
Q4 | $270K | Sell |
731
-22
| -3% | -$9.21K | 0.03% | 298 |
|
|
2024
Q3 | $392K | Sell |
753
-149
| -17% | -$79.6K | 0.05% | 240 |
|
|
2024
Q2 | $489K | Buy |
902
+27
| +3% | +$14.3K | 0.06% | 192 |
|
|
2024
Q1 | $454K | Buy |
875
+44
| +5% | +$21.9K | 0.06% | 200 |
|
|
2023
Q4 | $392K | Buy |
831
+40
| +5% | +$18.5K | 0.05% | 204 |
|
|
2023
Q3 | $344K | Buy |
791
+3
| +0.4% | +$1.36K | 0.05% | 204 |
|
|
2023
Q2 | $350K | Sell |
788
-5
| -0.6% | -$2.31K | 0.05% | 208 |
|
|
2023
Q1 | $365K | Buy |
793
+336
| +74% | +$160K | 0.05% | 220 |
|
|
2022
Q4 | $234K | Buy |
457
+11
| +2% | +$5.58K | 0.03% | 229 |
|
|
2022
Q3 | $203K | Hold |
446
| – | – | 0.04% | 210 |
|
|
2022
Q2 | $215K | Hold |
446
| – | – | 0.04% | 206 |
|
|
2022
Q1 | $219K | Sell |
446
-40
| -8% | -$18.3K | 0.03% | 243 |
|
|
2021
Q4 | $225K | Hold |
486
| – | – | 0.03% | 253 |
|
|
2021
Q3 | $181K | Buy |
486
+10
| +2% | +$3.8K | 0.02% | 290 |
|
|
2021
Q2 | $182K | Hold |
476
| – | – | 0.03% | 269 |
|
|
2021
Q1 | $171K | Sell |
476
-8
| -2% | -$2.57K | 0.03% | 271 |
|
|
2020
Q4 | $155K | Buy |
484
+8
| +2% | +$2.46K | 0.02% | 264 |
|
|
2020
Q3 | $128K | Sell |
476
-778
| -62% | -$209K | 0.02% | 254 |
|
|
2020
Q2 | $330K | Hold |
1,254
| – | – | 0.05% | 188 |
|
|
2020
Q1 | $285K | Buy |
1,254
+40
| +3% | +$10.9K | 0.05% | 187 |
|
|
2019
Q4 | $367K | Hold |
1,214
| – | – | 0.04% | 192 |
|
|
2019
Q3 | $291K | Hold |
1,214
| – | – | 0.03% | 207 |
|
|
2019
Q2 | $343K | Hold |
1,214
| – | – | 0.04% | 187 |
|
|
2019
Q1 | $348K | Buy |
1,214
+436
| +56% | +$126K | 0.04% | 178 |
|
|
2018
Q4 | $185K | Hold |
778
| – | – | 0.03% | 223 |
|
|
2018
Q3 | $213K | Hold |
778
| – | – | 0.03% | 220 |
|
|
2018
Q2 | $185K | Sell |
778
-23
| -3% | -$5.33K | 0.03% | 227 |
|
|
2018
Q1 | $176K | Buy |
801
+23
| +3% | +$5.4K | 0.03% | 219 |
|
|
2017
Q4 | $175K | Hold |
778
| – | – | 0.03% | 211 |
|
|
2017
Q3 | $148K | Hold |
778
| – | – | 0.02% | 212 |
|
|
2017
Q2 | $146K | Hold |
778
| – | – | 0.02% | 228 |
|
|
2017
Q1 | $129K | Hold |
778
| – | – | 0.02% | 242 |
|
|
2016
Q4 | $112K | Hold |
778
| – | – | 0.02% | 255 |
|
|
2016
Q3 | $97K | Sell |
778
-537
| -41% | -$69.3K | 0.01% | 282 |
|
|
2016
Q2 | $173K | Hold |
1,315
| – | – | 0.02% | 211 |
|
|
2016
Q1 | $183K | Hold |
1,315
| – | – | 0.03% | 213 |
|
|
2015
Q4 | $183K | Hold |
1,315
| – | – | 0.03% | 221 |
|
|
2015
Q3 | $184K | Hold |
1,315
| – | – | 0.03% | 210 |
|
|
2015
Q2 | $216K | Hold |
1,315
| – | – | 0.03% | 199 |
|
|
2015
Q1 | $203K | Sell |
1,315
-321
| -20% | -$45.7K | 0.03% | 201 |
|
|
2014
Q4 | $206K | Hold |
1,636
| – | – | 0.03% | 351 |
|
|
2014
Q3 | $196K | Hold |
1,636
| – | – | 0.03% | 350 |
|
|
2014
Q2 | $176K | Hold |
1,636
| – | – | 0.02% | 398 |
|
|
2014
Q1 | $163K | Hold |
1,636
| – | – | 0.03% | 383 |
|
|
2013
Q4 | $151K | Hold |
1,636
| – | – | 0.02% | 398 |
|
|
2013
Q3 | $137K | Hold |
1,636
| – | – | 0.02% | 407 |
|
|
2013
Q2 | $134K | Buy |
+1,636
| New | +$122K | 0.02% | 403 |
|
Other funds holding ELV
VCM
VPM
Manchester Capital Management's ELV Position: Q1 2026 in Review
Manchester Capital Management reduced its Elevance Health (ELV) stake by 11% in Q1 2026, selling an estimated $30.6K and leaving 788 shares worth $231K. The position accounts for 0.03% of the portfolio, ranked #251.
Manchester Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $489K in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Manchester Capital Management held 788 shares of Elevance Health worth $231K as of Q1 2026.
- Manchester Capital Management sold 93 Elevance Health shares in Q1 2026, an estimated $30.6K.
- Elevance Health made up 0.03% of Manchester Capital Management's portfolio in Q1 2026, its #251 holding.
- Manchester Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Manchester Capital Management's Elevance Health position peaked at $489K in Q2 2024.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.